The regulation of mast cell growth and differentiation depends upon the sequential availability of specific growth factors and the expression of their corresponding receptors. Among the various cytokines that promote mast cell growth, the most important is stem cell factor (SCF) which is produced in tissues by stromal cells. We have reported that the decrease in mast cells observed in tissues that follows topical steroid administration is due to the effect of the steroid on SCF production. In an effort to also identify cytokines that inhibit human mast cell growth, we cultured SCF-dependent human bone marrow-derived mast cells (HBMCs) in the presence of interferon (IFN) gamma-1b. In these cultures, HBMCs significantly decreased in number. IFN-gamma-1b was thus able to suppress mast cell growth from CD34-positive cells, suggesting that this agent should be considered as a candidate cytokine for the treatment of disorders of mast cell proliferation.We previously reported that human mast cells arise from CD34-positive human stem cells in SCF (c-kit positive). To further characterize the human mast cell precursor, we sorted CD34-positive cells using a variety of candidate markers. The most promising was CD13. A series of experiments based on cell sorting and colony formation then led to the conclusion that CD34-positive, c-kit-positive, CD13-positive cells gave rise to all mast cells in culture. In additional studies we have also demonstrated that mast cells express connexins which are involved in cell-to-cell communication. Finally, in studies in mast cell deficient mice we found that the Wv c-kit mutant allele remains able to induce a signal, which leads to adhesion. - Mast cells, stem cells, monocytes, cell culture, differentiation, colony formation, stem cell factor, IL3, IFN-gamma - Human Subjects

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000513-12
Application #
6288865
Study Section
Special Emphasis Panel (LAD)
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Bandara, Geethani; Beaven, Michael A; Olivera, Ana et al. (2015) Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33. Eur J Immunol 45:3034-44
Kulka, Marianna; Fukuishi, Nobuyuki; Metcalfe, Dean D (2009) Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily. J Leukoc Biol 86:1217-26
Metcalfe, Dean D (2008) Mast cells and mastocytosis. Blood 112:946-56
Soule, Benjamin P; Brown, Jared M; Kushnir-Sukhov, Nataliya M et al. (2007) Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol 179:3276-86
Carter, Melody C; Robyn, Jamie A; Bressler, Peter B et al. (2007) Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J Allergy Clin Immunol 119:1550-1
Swindle, Emily J; Metcalfe, Dean D (2007) The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol Rev 217:186-205
Kushnir-Sukhov, Nataliya M; Brown, Jared M; Wu, Yalin et al. (2007) Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol 119:498-9
Brown, Jared M; Swindle, Emily J; Kushnir-Sukhov, Nataliya M et al. (2007) Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 36:43-52
Sundstrom, J Bruce; Ellis, Jane E; Hair, Gregory A et al. (2007) Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109:5293-300
Prussin, Calman; Metcalfe, Dean D (2006) 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117:S450-6

Showing the most recent 10 out of 35 publications